Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- Mike Zach
- Alex Roschli
- Andrew F May
- Ben Garrison
- Brad Johnson
- Brian Post
- Bruce Moyer
- Cameron Adkins
- Charlie Cook
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Diana E Hun
- Gina Accawi
- Gurneesh Jatana
- Hsin Wang
- Isha Bhandari
- James Klett
- Jeffrey Einkauf
- Jennifer M Pyles
- John Lindahl
- John Wenzel
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Liam White
- Luke Sadergaski
- Mark Loguillo
- Mark M Root
- Michael Borish
- Nedim Cinbiz
- Padhraic L Mulligan
- Philip Boudreaux
- Sandra Davern
- Singanallur Venkatakrishnan
- Tony Beard

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

We have been working to adapt background oriented schlieren (BOS) imaging to directly visualize building leakage, which is fast and easy.

The technologies provide a system and method of needling of veiled AS4 fabric tape.

Neutron beams are used around the world to study materials for various purposes.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence